Cargando…

In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma

Detalles Bibliográficos
Autores principales: Cazzamalli, Samuele, Figueras, Eduard, Pethő, Lilla, Borbély, Adina, Steinkühler, Christian, Neri, Dario, Sewald, Norbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6644080/
https://www.ncbi.nlm.nih.gov/pubmed/31458304
http://dx.doi.org/10.1021/acsomega.8b03183
_version_ 1783437192560902144
author Cazzamalli, Samuele
Figueras, Eduard
Pethő, Lilla
Borbély, Adina
Steinkühler, Christian
Neri, Dario
Sewald, Norbert
author_facet Cazzamalli, Samuele
Figueras, Eduard
Pethő, Lilla
Borbély, Adina
Steinkühler, Christian
Neri, Dario
Sewald, Norbert
author_sort Cazzamalli, Samuele
collection PubMed
description
format Online
Article
Text
id pubmed-6644080
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-66440802019-08-27 In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma Cazzamalli, Samuele Figueras, Eduard Pethő, Lilla Borbély, Adina Steinkühler, Christian Neri, Dario Sewald, Norbert ACS Omega American Chemical Society 2018-12-05 /pmc/articles/PMC6644080/ /pubmed/31458304 http://dx.doi.org/10.1021/acsomega.8b03183 Text en Copyright © 2018 American Chemical Society This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution License (http://pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html) , which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes.
spellingShingle Cazzamalli, Samuele
Figueras, Eduard
Pethő, Lilla
Borbély, Adina
Steinkühler, Christian
Neri, Dario
Sewald, Norbert
In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma
title In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma
title_full In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma
title_fullStr In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma
title_full_unstemmed In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma
title_short In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma
title_sort in vivo antitumor activity of a novel acetazolamide–cryptophycin conjugate for the treatment of renal cell carcinoma
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6644080/
https://www.ncbi.nlm.nih.gov/pubmed/31458304
http://dx.doi.org/10.1021/acsomega.8b03183
work_keys_str_mv AT cazzamallisamuele invivoantitumoractivityofanovelacetazolamidecryptophycinconjugateforthetreatmentofrenalcellcarcinoma
AT figueraseduard invivoantitumoractivityofanovelacetazolamidecryptophycinconjugateforthetreatmentofrenalcellcarcinoma
AT petholilla invivoantitumoractivityofanovelacetazolamidecryptophycinconjugateforthetreatmentofrenalcellcarcinoma
AT borbelyadina invivoantitumoractivityofanovelacetazolamidecryptophycinconjugateforthetreatmentofrenalcellcarcinoma
AT steinkuhlerchristian invivoantitumoractivityofanovelacetazolamidecryptophycinconjugateforthetreatmentofrenalcellcarcinoma
AT neridario invivoantitumoractivityofanovelacetazolamidecryptophycinconjugateforthetreatmentofrenalcellcarcinoma
AT sewaldnorbert invivoantitumoractivityofanovelacetazolamidecryptophycinconjugateforthetreatmentofrenalcellcarcinoma